Cullinan Therapeutics, Inc. (NASDAQ:CGEM) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Stephen Webster Other companies: NextCure, Inc. (Director · Since at least May 8, 2019); Gritstone bio, Inc. (Director · Apr 26, 2024 – Apr 4, 2025 · Past); Tcr2 Therapeutics Inc (Director · Apr 30, 2020 – Jun 1, 2023 · Past); Nabriva Therapeutics AG (Director · Dec 30, 2016 – Aug 2, 2022 · Past); Viking Therapeutics, Inc. (Director · Apr 28, 2015 – Jan 2, 2020 · Past); Spark Therapeutics Inc (CHIEF FINANCIAL OFFICER · Jan 29, 2015 – Dec 17, 2019 · Past); Optimer Pharmaceuticals Inc (Chief Financial Officer · Jun 25, 2012 – Oct 24, 2013 · Past); Adolor Corp (SVP, Finance & CFO · Sep 9, 2010 – Dec 12, 2011 · Past) | Chair of the Audit Committee · Since at least Jan 7, 2021 |
| Owen Hughes Other companies: AnaptysBio, Inc. (Member of the Audit Committee · Since at least May 11, 2026); XOMA Royalty Corporation (Chief Executive Officer, Director · Since at least Nov 11, 2024); C4 Therapeutics, Inc. (Director · Since at least Nov 16, 2023); ImageneBio, Inc. (Director · Dec 14, 2022 – Jun 7, 2024 · Past); Pardes Biosciences Inc (Director · Feb 16, 2021 – Dec 23, 2021 · Past); Translate Bio Inc (Director · Jun 27, 2018 – Sep 14, 2021 · Past); Radius Health, Inc. (Director · Apr 23, 2013 – Aug 15, 2022 · Past) | President and CEO, Director · Jan 7, 2021 – Jan 12, 2021 · Past |
| Mary Thistle Other companies: Aktis Oncology, Inc. (Independent Director · Since at least Jan 8, 2026); Vigil Neuroscience Inc (Director · Since at least Apr 18, 2022); Entrada Therapeutics, Inc. (Industry Leader and Independent Director · Since at least Oct 28, 2021); Q32 Bio Inc. (Director · Since at least Mar 27, 2018); Alaunos Therapeutics, Inc. (Director · Nov 15, 2020 – Jun 6, 2023 · Past); Dimension Therapeutics (Chief Operating Officer · Feb 1, 2017 – Nov 7, 2017 · Past) | Chair of the Compensation Committee · Since at least Aug 8, 2024 |
| David Meek Other companies: uniQure N.V. (Chairman of the Board · Since at least Feb 25, 2021); Fusion Pharmaceuticals Inc (Director · Oct 16, 2023 – Jun 4, 2024 · Past); Entasis Therapeutics Holdings Inc (Director · Jun 10, 2020 – Jul 7, 2022 · Past) | Director · Since at least May 15, 2024 |
| Mary Kay Fenton Other companies: Tourmaline Bio Inc. (Chief Financial Officer · May 6, 2021 – Jul 3, 2023 · Past); Oncorus Inc (Director · Oct 1, 2020 – Jun 23, 2022 · Past); Achillion Pharmaceuticals Inc (Chief Financial Officer · Dec 12, 2011 – Feb 9, 2018 · Past) | Chief Financial Officer · Since at least Apr 29, 2024 |
| Nadim Ahmed Other companies: Disc Medicine, Inc. (Director · Since at least Jul 14, 2025); Bristol-Myers Squibb Company (EVP and President, Hematology · Nov 20, 2019 – Dec 31, 2020 · Past); Celgene Corporation (PRES., GLOBAL HEM. AND ONC. · Jun 13, 2018 – Nov 20, 2019 · Past) | President and Chief Executive Officer · Since at least Oct 18, 2021 |
| Morana Jovan-Embiricos Other companies: Kalaris Therapeutics, Inc. (Director · Since at least Jul 29, 2020); Tcr2 Therapeutics Inc (Director · Feb 13, 2019 – Feb 19, 2019 · Past) | Director · Jan 7, 2021 – Sep 16, 2021 · Past |
| Jeffrey Trigilio Other companies: XOMA Royalty Corporation (Chief Financial Officer · Since at least Jan 12, 2026) | Chief Financial Officer · Jan 7, 2021 – Feb 22, 2024 · Past |
| Mittie Doyle Other companies: Avalo Therapeutics, Inc. (Chief Medical Officer · Since at least Jul 15, 2024) | Director · Since at least Aug 7, 2025 |
| Tony Rosenberg Other companies: Radius Health, Inc. (Director · Feb 13, 2018 – Feb 26, 2020 · Past) | Director · Since at least Jan 7, 2021 |
| Andrew Allen | Member of the Compensation Committee · Since at least Aug 7, 2025 |
| Anne-Marie Martin | Director · Since at least Mar 1, 2022 |
| Corrine Savill | Chief Business Officer · Since at least Jul 11, 2022 |
| David P Ryan | Director · Since at least Nov 1, 2022 |
| Jeffrey Alan Jones | Chief Medical Officer · Since at least Feb 28, 2022 |
| Nate Nguyen | Interim PAO and PFO · Mar 29, 2024 – Mar 29, 2024 · Past |
| Thomas Ebeling | Director · Jan 7, 2021 – Jun 10, 2024 · Past |